Rational approach to genetic testing of cystic fibrosis (CF) in infertile men |
| |
Authors: | Mennicke K Klingenberg R D Bals-Pratsch M Diedrich K Schwinger E |
| |
Affiliation: | Human Genetics, University Clinic of Schleswig-Holstein, Lübeck, Germany. mennicke@paedia.ukl.mu-luebeck.de |
| |
Abstract: | Male infertility as a result of isolated congenital bilateral absence of the vas deferens (CBAVD) is one primary genital form of cystic fibrosis (CF) and occurs in 1-2% of infertile men. Assisted fertilization in patients with CBAVD increases the risk of transmitting mutations in the CF gene. We developed a rational approach to genetic CF testing in infertile men. A total of 282 infertile male patients were screened for the most common CF mutations (DeltaF508, R117H, IVS8-5T). Clinical data including medical history, examination, semen analysis, sweat tests, karyotypes and hormonal values were analysed. We identified 23 patients carrying mutations in the CF gene (DeltaF508: 10 patients; R117H: six patients; IVS8-5T: 11 patients). Two patients were compound heterozygote for DeltaF508/R117H, two others for DeltaF508/IVS8-5T. Correlating these molecular analyses with the clinical data pertaining to serum follicle-stimulating hormone concentration, semen pH, sperm count and total testicular volume, we were able to develop a score with a high specificity (98.4) for the presence of a cystic fibrosis transmembrane conductance regulator (CFTR) mutation, but only with a low sensitivity (positive post-test likelihood: 62.5%; negative post-test likelihood: 6.3%). With regard to the low sensitivity and the high number of CFTR mutations found in this heterogeneous group of infertile men, we still recommend genetic CF testing before assisted fertilization. |
| |
Keywords: | Clinical score congenital bilateral absence of the vas deferens (CBAVD) cystic fibrosis transmembrane conductance regulator (CFTR) genetic testing male infertility |
本文献已被 PubMed 等数据库收录! |
|